Haleon plc (HLN)
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Sector: Perfumes, Cosmetics & Other Toilet Preparations
Industry: Drug Manufacturers - Specialty & Generic
Haleon plc
| Form | Description | Links | |
|---|---|---|---|
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| CERT | |||
| 8-A12B | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 6-K | |||
| 424B5 | |||
| 6-K | |||
| FWP | |||
| 6-K | |||
| 6-K | |||
| 424B5 | |||
| POSASR | |||
| 6-K | |||
| 6-K/A | |||
| 6-K |
1-25 of 528 filings
Recent SEC filings with analysis
- 6-KHaleon plc filed a 6-K disclosing a PDMR shareholding notification under UK Market Abuse Regulation requirements.
- 6-KHaleon plc filed a routine 6-K disclosing its total voting rights and capital as of 31 October 2026.
- 6-KHaleon plc announced the purchase of 4,492,636 ordinary shares under its share buyback programme announced on 29 October 2026, to be held as treasury shares.
- 6-KHaleon plc announced the commencement of a share buyback programme of up to £500 million, first flagged in its Q3 2026 trading statement on 29 October 2026.
- 6-KHaleon plc filed a Form 6-K on 29 October 2026 announcing the release of its Q3 2026 trading statement, with the full text hosted via a London Stock Exchange…
- 6-KHaleon plc filed a routine 6-K disclosing its total voting rights and capital as of 30 September 2026.
- 6-KHaleon plc filed a 6-K on 24 September 2026 disclosing UK Market Abuse Regulation notifications of share transactions by Persons Discharging Managerial…
- 6-KHaleon plc filed a Form 6-K containing a Director/PDMR shareholding notification made under the UK Market Abuse Regulation.